The efficacy and safety of irsogladine maleate in nonsteroidal anti-inflammatory drug or aspirin-induced peptic ulcer and gastritis

키워드

참고문헌 (47)

1. Coxib and traditional NSAID Trialists' (CNT) Collaboration, "Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials", Lancet, 382, pp.769~779 (2013)
2. Sostres C, "Nonsteroidal anti-inflammatory drugs and upper and lower gastrointestinal mucosal damage", Arthritis Res Ther, (15 Suppl 3), pp.S3~ (2013)
3. Lanza FL, "A review of gastric ulcer and gastroduodenal injury in normal volunteers receiving aspirin and other non-steroidal anti-inflammatory drugs", Scand J Gastroenterol Suppl, 163, pp.24~31 (1989)
4. 김진주, "소화성궤양 발생 및 재발의 위험인자", 대한소화기학회지, 56(4), pp.220~228 (2010), 대한소화기학회
5. Bae S, "Incidence and 30-day mortality of peptic ulcer bleeding in Korea", Eur J Gastroenterol Hepatol, 24, pp.675~682 (2012)
6. Bae S, "Incidence and short-term mortality from perforated peptic ulcer in Korea : a population-based study", J Epidemiol, 22, pp.508~516 (2012)
7. Kang JM, "Effect of aging on gastric mucosal defense mechanisms : ROS, apoptosis, angiogenesis, and sensory neurons", Am J Physiol Gastrointest Liver Physiol, 299, pp.G1147~G1153 (2010)
8. Sung JJ, "Asia-Pacific Working Group consensus on non-variceal upper gastrointestinal bleeding", Gut, 60, pp.1170~1177 (2011)
9. 송현진, "Cost Effectiveness Associated with Helicobacter pylori Screening and Eradication in Patients Taking Nonsteroidal Anti-Inflammatory Drugs and", or Aspirin, 2013, pp.7(2), 182~189[DOI]
10. Malfertheiner P, "Management of Helicobacter pylori infection : the Maastricht IV", Florence Consensus Report, 2012, pp.61, 646~664
11. Cryer B, "Effects of very low dose daily, longterm aspirin therapy on gastric, duodenal, and rectal prostaglandin levels and on mucosal injury in healthy humans", Gastroenterology, 117, pp.17~25 (1999)
12. Goldstein JL, "The impact of low-dose aspirin on endoscopic gastric and duodenal ulcer rates in users of a non-selective non-steroidal anti-inflammatory drug or a cyclo-oxygenase-2-selective inhibitor", Aliment Pharmacol Ther, 23, pp.1489~1498 (2006)
13. Hernandez-Diaz S, "Cardioprotective aspirin users and their excess risk of upper gastrointestinal complications", BMC Med, 4, pp.22~ (2006)
14. Niv Y, "Endoscopy in asymptomatic minidose aspirin consumers", Dig Dis Sci, 50, pp.78~80 (2005)
15. Yeomans ND, "Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin", Aliment Pharmacol Ther, 22, pp.795~801 (2005)
16. 정대영, "비출혈 소화성궤양 치료의 가이드라인", 대한소화기학회지, 54(5), pp.285~297 (2009), 대한소화기학회
17. Ali T, "Long-term safety concerns with proton pump inhibitors", Am J Med, 122, pp.896~903 (2009)
18. Kyoi T, "Irsogladine, an anti-ulcer drug, suppresses superoxide production by inhibiting phosphodiesterase type 4 in human neutrophils", Life Sci, 76, pp.71~83 (2004)
19. Ueda F, "Beta-adrenergic regulation of gap-junctional intercellular communication in cultured rabbit gastric epithelial cells", J Pharmacol Exp Ther, 271, pp.397~402 (1994)
20. Kyoi T, "Irsogladine prevents monochloramine-induced gastric mucosal lesions by improving the decrease in mucosal blood flow due to the disturbance of nitric oxide synthesis in rats", J Pharmacol Sci, 93, pp.314~320 (2003)
21. Sato M, "Effect of irsogladine maleate on NSAID-induced reduction of gastric mucosal blood flow in anesthetized dogs", Digestion, 79, pp.73~78 (2009)
22. Tatsumi Y, "Irsogladine maleate may preserve gastric mucosal hydrophobicity against ethanol in phospholipids independent way in rats", Jpn J Pharmacol, 77, pp.293~299 (1998)
23. Desai JC, "Primary prevention of adverse gastroduodenal effects from short-term use of non-steroidal anti-inflammatory drugs by omeprazole 20mg in healthy subjects : a randomized, double-blind, placebo-controlled study", Dig Dis Sci, 53, pp.2059~2065 (2008)
24. Graham DY, "Prevention of NSAID-induced gastric ulcer with misoprostol : multicentre, double-blind, placebo-controlled trial", Lancet, 2, pp.1277~1280 (1988)
25. Laine L, "Nonsteroidal anti-inflammatory drug gastropathy", Gastrointest Endosc Clin N Am, 6, pp.489~504 (1996)
26. Laine L, "The gastrointestinal effects of nonselective NSAIDs and COX-2-selective inhibitors", Semin Arthritis Rheum, 32(3 Suppl 1), pp.25~32 (2002)
27. 이오영, "A comparative study of DA-9601 and misoprostol for prevention of NSAID-associated gastroduodenal injury in patients undergoing chronic NSAID treatment", Archives of Pharmacal Research, 37(10), pp.1308~1316 (2014), 대한약학회[DOI]
28. Niwa Y, "Efficacy of rebamipide for diclofenac-induced small-intestinal mucosal injuries in healthy subjects : a prospective, randomized, double-blinded, placebo-controlled, cross-over study", J Gastroenterol, 43, pp.270~276 (2008)
29. Thongbai T, "The prevalence of gastroduodenal mucosal injuries in aspirin users", J Med Assoc Thai, 96, pp.1423~1427 (2013)
30. Zhang S, "Rebamipide helps defend against nonsteroidal anti-inflammatory drugs induced gastroenteropathy : a systematic review and meta-analysis", Dig Dis Sci, 58, pp.1991~2000 (2013)
31. 조현진, "The Effect of Cochinchina momordica Seed Extract on Gastric Acid Secretion and Morphologic Change in Aged Rat Stomach", Gut and Liver, 7(5), pp.560~568 (2013), 거트앤리버 소화기연관학회협의회
32. Lanza FL, "Ethanol, aspirin, ibuprofen, and the gastroduodenal mucosa : an endoscopic assessment", Am J Gastroenterol, 80, pp.767~769 (1985)
33. Lanza FL, "Endoscopic studies of gastric and duodenal injury after the use of ibuprofen, aspirin, and other nonsteroidal anti-inflammatory agents", Am J Med, 77, pp.19~24 (1984)
34. Tytgat GN, "The Sydney System: endoscopic division. Endoscopic appearances in gastritis", duodenitis, 1991, pp.6, 223~234
35. Smolka AJ, "How Helicobacter pylori infection controls gastric acid secretion", J Gastroenterol, 47, pp.609~618 (2012)
36. Beales IL, "Interleukin 1 beta and tumour necrosis factor alpha inhibit acid secretion in cultured rabbit parietal cells by multiple pathways", Gut, 42, pp.227~234 (1998)
37. Kim N, "Helicobacter pylori", pp.53~76 (2016), Springer Co
38. Choi KD, "Optimal dose of intravenous pantoprazole in patients with peptic ulcer bleeding requiring endoscopic hemostasis in Korea", J Gastroenterol Hepatol, 24, pp.1617~1624 (2009)
39. Goggin PM, "Prevalence of Helicobacter pylori infection and its effect on symptoms and non-steroidal anti-inflammatory drug induced gastrointestinal damage in patients with rheumatoid arthritis", Gut, 34, pp.1677~1680 (1993)
40. Kim JG, "Helicobacter pylori infection and development of gastric or duodenal ulcer in arthritic patients receiving chronic NSAID therapy. The Misoprostol Study Group", Am J Gastroenterol, 89, pp.203~207 (1994)
41. Laine L, "Interaction of NSAIDs and Helicobacter pylori on gastrointestinal injury and prostaglandin production : a controlled double-blind trial", Aliment Pharmacol Ther, 9, pp.127~135 (1995)
42. Lanza FL, "Effect of Helicobacter pylori infection on the severity of gastroduodenal mucosal injury after the acute administration of naproxen or aspirin to normal volunteers", Am J Gastroenterol, 86, pp.735~737 (1991)
43. Thillainayagam AV, "Interrelationships between Helicobacter pylori infection, nonsteroidal antiinflammatory drugs and gastroduodenal disease. A prospective study in healthy volunteers", Dig Dis Sci, 39, pp.1085~1089 (1994)
44. Akagi M, "Irsogladine : overview of the mechanisms of mucosal protective and healing-promoting actions in the gastrointestinal tract", Curr Pharm Des, 19, pp.106~114 (2013)
45. Kuramoto T, "Preventive effect of irsogladine or omeprazole on non-steroidal anti-inflammatory drug-induced esophagitis, peptic ulcers, and small intestinal lesions in humans, a prospective randomized controlled study", BMC Gastroenterol, 13, pp.85~ (2013)
46. Murakami K, "Comparison of the efficacy of irsogladine maleate and famotidine for the healing of gastric ulcers after Helicobacter pylori eradication therapy : a randomized, controlled, prospective study", Scand J Gastroenterol, 46, pp.287~292 (2011)
47. Sung JJ, "Systematic review : the global incidence and prevalence of peptic ulcer disease", Aliment Pharmacol Ther, 29, pp.938~946 (2009)

관련 논문AI추천